Ireland
# |
Name |
EBITDA |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 11.76 B
|
Nov. 30, 2024 | USD 348.99 | -0.04% |
|
Ireland |
|
2 |
USD 9.19 B
|
Oct. 25, 2024 | USD 85.25 | 4.23% |
|
Ireland |
|
3 |
USD 6.02 B
|
Dec. 31, 2023 | USD 92.69 | 1.24% |
|
Ireland |
|
4 |
USD 4.90 B
|
Dec. 31, 2023 | USD 340.14 | -0.22% |
|
Ireland |
|
5 |
USD 4.55 B
|
Dec. 31, 2023 | USD 95.81 | 1.17% |
|
Ireland |
|
6 |
USD 3.91 B
|
Dec. 31, 2023 | USD 362.65 | 2.25% |
|
Ireland |
|
7 |
USD 3.30 B
|
March 31, 2024 | USD 19.10 | 2.60% |
|
Ireland |
|
8 |
USD 3.15 B
|
Dec. 31, 2023 | USD 382.71 | 1.52% |
|
Ireland |
|
9 |
USD 2.77 B
|
Sept. 30, 2024 | USD 80.21 | 1.15% |
|
Ireland |
|
10 |
USD 2.53 B
|
Dec. 31, 2023 | USD 61.47 | 1.42% |
|
Ireland |
|
11 |
USD 2.42 B
|
March 31, 2024 | USD 42.18 | 0.76% |
|
Ireland |
|
12 |
USD 2.28 B
|
Dec. 31, 2023 | USD 52.93 | 1.48% |
|
Ireland |
|
13 |
USD 1.52 B
|
Dec. 31, 2023 | USD 200.24 | -8.14% |
|
Ireland |
|
14 |
USD 1.49 B
|
Sept. 27, 2024 | USD 91.23 | 2.59% |
|
Ireland |
|
15 |
USD 1.34 B
|
Sept. 30, 2024 | USD 207.57 | 0.10% |
|
Ireland |
|
16 |
USD 1.32 B
|
Dec. 31, 2023 | USD 93.99 | 0.60% |
|
Ireland |
|
17 |
USD 1.23 B
|
Dec. 31, 2023 | USD 122.96 | -0.16% |
|
Ireland |
|
18 |
USD 1.20 B
|
Dec. 31, 2023 | USD 67.20 | 1.30% |
|
Ireland |
|
19 |
USD 1.11 B
|
March 31, 2024 | USD 61.59 | -0.70% |
|
Ireland |
|
20 |
USD 976.20 M
|
March 31, 2024 | USD 31.56 | 3.45% |
|
Ireland |
|
21 |
USD 819.30 M
|
Dec. 31, 2023 | USD 129.75 | 1.16% |
|
Ireland |
|
22 |
USD 772.00 M
|
Sept. 30, 2024 | USD 17.44 | 1.99% |
|
Ireland |
|
23 |
USD 653.00 M
|
Dec. 31, 2023 | USD 259.60 | 1.17% |
|
Ireland |
|
24 |
USD 618.76 M
|
Dec. 31, 2023 | USD 14.10 | 1.95% |
|
Ireland |
|
25 |
USD 525.00 M
|
Dec. 31, 2023 | USD 23.51 | -3.41% |
|
Ireland |
|
26 |
USD 519.48 M
|
Dec. 31, 2023 | USD 28.50 | 0.53% |
|
Ireland |
|
27 |
USD 424.19 M
|
Dec. 31, 2023 | USD 10.39 | 0.85% |
|
Ireland |
|
28 |
USD 419.40 M
|
Dec. 31, 2023 | USD 5.70 | NA |
|
Ireland |
|
29 |
USD 391.21 M
|
Dec. 31, 2023 | USD 12.82 | 3.22% |
|
Ireland |
|
30 |
USD 389.40 M
|
Sept. 30, 2024 | USD 71.41 | 0.03% |
|
Ireland |
|
31 |
USD 249.50 M
|
Dec. 31, 2023 | USD 4.84 | 3.24% |
|
Ireland |
|
32 |
USD 223.75 M
|
Dec. 31, 2023 | USD 4.02 | 4.91% |
|
Ireland |
|
33 |
USD 197.66 M
|
Sept. 30, 2024 | USD 2.07 | -1.42% |
|
Ireland |
|
34 |
USD 147.90 M
|
Dec. 31, 2023 | USD 5.42 | 2.16% |
|
Ireland |
|
35 |
USD 127.07 M
|
Dec. 31, 2023 | USD 2.12 | -1.78% |
|
Ireland |
|
36 |
USD 121.84 M
|
Dec. 31, 2023 | USD 2.05 | 2.67% |
|
Ireland |
|
37 |
USD 121.78 M
|
July 31, 2024 | USD 2.75 | -0.51% |
|
Ireland |
|
38 |
USD 108.91 M
|
Dec. 31, 2023 | USD 12.99 | -0.97% |
|
Ireland |
|
39 |
USD 81.35 M
|
Dec. 31, 2023 | USD 1.53 | -1.39% |
|
Ireland |
|
40 |
USD 21.74 M
|
Dec. 31, 2023 | USD 69.11 | -2.10% |
|
Ireland |
|
41 |
USD 20.20 M
|
Dec. 31, 2023 | USD 0.45 | 0.01% |
|
Ireland |
|
42 |
USD 5.75 M
|
Dec. 31, 2023 | USD 1.68 | 1.94% |
|
Ireland |
|
43 |
USD 0.00
|
Dec. 31, 2023 | USD 5.75 | 1.52% |
|
Ireland |
|
44 |
USD 0.00
|
Dec. 31, 2023 | USD 9.35 | 1.50% |
|
Ireland |
|
45 |
USD 0.00
|
Dec. 31, 2023 | USD 1.42 | 1.34% |
|
Ireland |
|
46 |
USD -336.04 K
|
Dec. 31, 2023 | USD 0.01 | 9.53% |
|
Ireland |
|
47 |
USD -605.96 K
|
Dec. 31, 2023 | USD 0.02 | -6.17% |
|
Ireland |
|
48 |
USD -957.00 K
|
Dec. 31, 2023 | USD 0.01 | -2.57% |
|
Ireland |
|
49 |
USD -4.21 M
|
Dec. 31, 2023 | USD 4.34 | 1.19% |
|
Ireland |
|
50 |
USD -14.18 M
|
Dec. 31, 2023 | USD 1.18 | 0.24% |
|
Ireland |
The company in Ireland with the highest EBITDA is Accenture plc (NYSE: ACN) at USD 11.76 B.
The company in Ireland with the lowest EBITDA is Mural Oncology plc (NasdaqGM: MURA) at USD -192.72 M.
The top 10 companies in Ireland by EBITDA are Accenture plc, Medtronic plc, CRH plc, Eaton Corporation plc, AerCap Holdings N.V., Aon plc, Ryanair Holdings plc, Trane Technologies plc, Johnson Controls International plc and Aptiv PLC.
The bottom 10 companies in Ireland by EBITDA are Mural Oncology plc, Prothena Corporation plc, Avadel Pharmaceuticals plc, Navitas Semiconductor Corporation, C&C Group plc, ADS-TEC Energy PLC, GH Research PLC, Iterum Therapeutics plc, FINEOS Corporation Holdings plc and kneat.com, inc..